% | $
Quotes you view appear here for quick access.

Roche Holding AG Message Board

  • gs_energy gs_energy Nov 28, 2011 3:08 PM Flag

    Roche to acquire Catalyst Pharmaceutical Partners

    to address worldwide alcohol and cocaine addition markets.

    They recently completed acquisition of Anadys (to address Hep C market) for a 300% premium to Anadys stock price. Given the revenue generation from their drug platform in these markets, we expect a very similar valuation ($3.67/share) applied to the tender offer price for Catalyst Pharmaceutical Partners.

33.53+0.09(+0.27%)Oct 6 4:00 PMEDT